{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:20:07Z","timestamp":1782260407232,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,23]]},"DOI":"10.7759\/cureus.70021","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:29:09Z","timestamp":1727119749000},"source":"Crossref","is-referenced-by-count":4,"title":["Cannabinoids as a Natural Alternative for the Management of Neuropathic Pain: A Systematic Review of Randomized Placebo-Controlled Trials"],"prefix":"10.7759","author":[{"given":"Driti","family":"Reechaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Laure Annaick","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashil","family":"Jahajeeah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateema","family":"Dookhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajit","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179407","article-title":"Opioid and cannabinoid systems in pain: emerging molecular mechanisms and use in clinical practice, health, and fitness","volume":"25","author":"Secondulfo C","year":"2024","unstructured":"Secondulfo C, Mazzeo F, Pastorino GM, Vicidomini A, Meccariello R, Operto FF. Opioid and cannabinoid systems in pain: emerging molecular mechanisms and use in clinical practice, health, and fitness. Int J Mol Sci. 2024, 25:10.3390\/ijms25179407","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa R","year":"2021","unstructured":"Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021, 22:3891. 10.3390\/ijms22083891","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788186272","article-title":"Neuropathic pain: models and mechanisms","volume":"15","author":"Jarvis MF","year":"2009","unstructured":"Jarvis MF, Boyce-Rustay JM. Neuropathic pain: models and mechanisms. Curr Pharm Des. 2009, 15:1711-6. 10.2174\/138161209788186272","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08195-6","article-title":"Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC\/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial","volume":"25","author":"Gurgenci T","year":"2024","unstructured":"Gurgenci T, Hardy J, Huggett G, et al.. Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC\/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. Trials. 2024, 25:350. 10.1186\/s13063-024-08195-6","journal-title":"Trials"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1148","article-title":"Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings","volume":"22","author":"L\u00f6tsch J","year":"2018","unstructured":"L\u00f6tsch J, Weyer-Menkhoff I, Tegeder I. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. Eur J Pain. 2018, 22:471-84. 10.1002\/ejp.1148","journal-title":"Eur J Pain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2019.06.009","article-title":"Cannabis use motivations among adults prescribed opioids for pain versus opioid addiction","volume":"21","author":"Clem SN","year":"2020","unstructured":"Clem SN, Bigand TL, Wilson M. Cannabis use motivations among adults prescribed opioids for pain versus opioid addiction. Pain Manag Nurs. 2020, 21:43-7. 10.1016\/j.pmn.2019.06.009","journal-title":"Pain Manag Nurs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00096-8","article-title":"Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions","volume":"3","author":"Furrer D","year":"2021","unstructured":"Furrer D, Kr\u00f6ger E, Marcotte M, et al.. Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. J Cannabis Res. 2021, 3:41. 10.1186\/s42238-021-00096-8","journal-title":"J Cannabis Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years","volume":"75","author":"Maccarrone M","year":"2023","unstructured":"Maccarrone M, Di Marzo V, Gertsch J, et al.. Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years. Pharmacol Rev. 2023, 75:885-958. 10.1124\/pharmrev.122.000600","journal-title":"Pharmacol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c00129","article-title":"Axially chiral cannabinoids: design, synthesis, and cannabinoid receptor affinity","volume":"145","author":"Kearney SE","year":"2023","unstructured":"Kearney SE, Gangano AJ, Barrus DG, et al.. Axially chiral cannabinoids: design, synthesis, and cannabinoid receptor affinity. J Am Chem Soc. 2023, 145:13581-91. 10.1021\/jacs.3c00129","journal-title":"J Am Chem Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.001121","article-title":"The development of cannabinoids as therapeutic agents in the United States","volume":"76","author":"Murray CH","year":"2024","unstructured":"Murray CH, Gannon BM, Winsauer PJ, Cooper ZD, Delatte MS. The development of cannabinoids as therapeutic agents in the United States. Pharmacol Rev. 2024, 76:915-55. 10.1124\/pharmrev.123.001121","journal-title":"Pharmacol Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness LA","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006293","article-title":"Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity","volume":"91","author":"Weizman L","year":"2018","unstructured":"Weizman L, Dayan L, Brill S, Nahman-Averbuch H, Hendler T, Jacob G, Sharon H. Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity. Neurology. 2018, 91:e1285-94. 10.1212\/WNL.0000000000006293","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/1389201020666191202111534","article-title":"The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities","volume":"21","author":"Xu DH","year":"2020","unstructured":"Xu DH, Cullen BD, Tang M, Fang Y. The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities. Curr Pharm Biotechnol. 2020, 21:390-402. 10.2174\/1389201020666191202111534","journal-title":"Curr Pharm Biotechnol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01085-0","article-title":"Oral delta-9-tetrahydrocannabinol (THC) increases parasympathetic activity and supraspinal conditioned pain modulation in chronic neuropathic pain male patients: a crossover, double-blind, placebo-controlled trial","volume":"38","author":"Weizman L","year":"2024","unstructured":"Weizman L, Sharon H, Dayan L, et al.. Oral delta-9-tetrahydrocannabinol (THC) increases parasympathetic activity and supraspinal conditioned pain modulation in chronic neuropathic pain male patients: a crossover, double-blind, placebo-controlled trial. CNS Drugs. 2024, 38:375-85. 10.1007\/s40263-024-01085-0","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1605","article-title":"The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: a randomized, double-blinded, placebo-controlled trial","volume":"24","author":"Almog S","year":"2020","unstructured":"Almog S, Aharon-Peretz J, Vulfsons S, et al.. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: a randomized, double-blinded, placebo-controlled trial. Eur J Pain. 2020, 24:1505-16. 10.1002\/ejp.1605","journal-title":"Eur J Pain"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa303","article-title":"Ingestion of a THC-rich cannabis oil in people with fibromyalgia: a\u00a0randomized, double-blind, placebo-controlled clinical trial","volume":"21","author":"Chaves C","year":"2020","unstructured":"Chaves C, Bittencourt PC, Pelegrini A. Ingestion of a THC-rich cannabis oil in people with fibromyalgia: a\u00a0randomized, double-blind, placebo-controlled clinical trial. Pain Med. 2020, 21:2212-8. 10.1093\/pm\/pnaa303","journal-title":"Pain Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli E","year":"2019","unstructured":"Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019, 33:2058738419838383. 10.1177\/2058738419838383","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00879-w","article-title":"Cannabis-based medicines and medical cannabis for chronic neuropathic pain","volume":"36","author":"Petzke F","year":"2022","unstructured":"Petzke F, T\u00f6lle T, Fitzcharles MA, H\u00e4user W. Cannabis-based medicines and medical cannabis for chronic neuropathic pain. CNS Drugs. 2022, 36:31-44. 10.1007\/s40263-021-00879-w","journal-title":"CNS Drugs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-020-00615-2","article-title":"Role of the anterior cingulate cortex in translational pain research","volume":"37","author":"Xiao X","year":"2021","unstructured":"Xiao X, Ding M, Zhang YQ. Role of the anterior cingulate cortex in translational pain research. Neurosci Bull. 2021, 37:405-22. 10.1007\/s12264-020-00615-2","journal-title":"Neurosci Bull"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00147","article-title":"Linking pain sensation to the autonomic nervous system: the role of the anterior cingulate and periaqueductal gray resting-state networks","volume":"14","author":"Hohenschurz-Schmidt DJ","year":"2020","unstructured":"Hohenschurz-Schmidt DJ, Calcagnini G, Dipasquale O, et al.. Linking pain sensation to the autonomic nervous system: the role of the anterior cingulate and periaqueductal gray resting-state networks. Front Neurosci. 2020, 14:147. 10.3389\/fnins.2020.00147","journal-title":"Front Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.18.12287-5","article-title":"The role of cannabinoids in pain control: the good, the bad, and the ugly","volume":"84","author":"Pergolizzi JV Jr","year":"2018","unstructured":"Pergolizzi JV Jr, Lequang JA, Taylor R Jr, Raffa RB, Colucci D. The role of cannabinoids in pain control: the good, the bad, and the ugly. Minerva Anestesiol. 2018, 84:955-69. 10.23736\/S0375-9393.18.12287-5","journal-title":"Minerva Anestesiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/297124-cannabinoids-as-a-natural-alternative-for-the-management-of-neuropathic-pain-a-systematic-review-of-randomized-placebo-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:29:11Z","timestamp":1727119751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/297124-cannabinoids-as-a-natural-alternative-for-the-management-of-neuropathic-pain-a-systematic-review-of-randomized-placebo-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.70021","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}